July 27, 2016 2:05 PM ET

Biotechnology

Company Overview of Synta Pharmaceuticals Corp.

Company Overview

Synta Pharmaceuticals Corp. focuses on the research, development, and commercialization of novel oncology medicines for cancer patients. Its clinical stage drug candidate in oncology is ganetespib, an Hsp90 inhibitor, which is in Phase II clinical trials to evaluate the combination of ganetespib and paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer; and in Phase I/II trial in combination with the mTOR inhibitor sirolimus in patients with refractory sarcoma, including malignant peripheral nerve sheath tumors. The company’s drug candidate in its Hsp90-inhibitor Drug Conjugate program is STA-12-8666, which is in preclinical trials for chemotherapy irinotecan. Synta...

45 Hartwell Avenue

Lexington, MA 02421

United States

Founded in 2000

10 Employees

Phone:

781-274-8200

Fax:

781-274-8228

Key Executives for Synta Pharmaceuticals Corp.

Chief Executive Officer, President and Director
Age: 44
Total Annual Compensation: $777.0K
Chief Financial Officer, Senior Vice President and Treasurer
Age: 62
Total Annual Compensation: $492.7K
Senior Vice President and General Counsel
Age: 48
Total Annual Compensation: $425.4K
Compensation as of Fiscal Year 2015.

Synta Pharmaceuticals Corp. Key Developments

Synta Pharmaceuticals Corp.(NasdaqCM:MDGL) dropped from S&P Global BMI Index

Synta Pharmaceuticals Corp.(NasdaqCM:MDGL) dropped from S&P Global BMI Index

Synta Pharmaceuticals Corp.(NasdaqCM:MDGL) dropped from NASDAQ Composite Index

Synta Pharmaceuticals Corp. has been removed from Nasdaq Composite Index.

Synta Pharmaceuticals Corp.(NasdaqCM:SNTA) dropped from Russell 2000 Index

Synta Pharmaceuticals Corp. has been removed from Russell 2000 Index.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
April 14, 2016
--
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Synta Pharmaceuticals Corp., please visit www.syntapharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.